Mysimba®
Mysimba® is a prescription weight loss treatment combining naltrexon and bupropion to reduce appetite and promote early satiety, aiding in weight loss. It is intended for adults with overweight or obesity as part of a comprehensive approach including diet, exercise, and sleep.
- The description claims Mysimba® is suitable for individuals with a BMI of 30 or higher, or 27 with health risks.
Variants (1)
- Default Title — 239.80 EUR — In stock
AI Readiness
Good foundation, but some important product data is still missing.
70%